• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 6 of 19
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
Health
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
By Cristin Flanagan and BloombergJune 8, 2021
Celmatix founder and CEO Piraye Beim wants to delay menopause by 15 years.
MPW
This biotech startup thinks it can delay menopause by 15 years. That would transform women’s lives
By Beth KowittApril 19, 2021
Meet the most innovative and inventive pharmaceutical companies of 2021
Health
Meet the most innovative and inventive pharmaceutical companies of 2021
By Sy Mukherjee and IDEA PharmaApril 16, 2021
What Genentech is doing to fix biotech’s diversity problem
Leadership
What Genentech is doing to fix biotech’s diversity problem
By Fortune EditorsApril 7, 2021
Photo of CytoSeek CEO Carolyn Porter
Tech
New venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells
By Jeremy KahnMarch 16, 2021
A man with his shirt off and wearing a mask receives a COVID-19 vaccination from a health worker wearing PPE.
Health
As mutant COVID variants multiply, the hunt is on for a ‘universal’ kill-all vaccine
By Jeremy KahnFebruary 19, 2021
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
Tech
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
By Jeremy KahnNovember 30, 2020
Photo of Air Street Capital Founder Nathan Benaich.
Tech
Twitter and a Supercell billionaire are backing a new A.I.-focused venture capital fund
By Jeremy KahnOctober 30, 2020
OneUnited Bank CEO Kevin Cohee
Finance
Biogen moves $10 million to Black-owned OneUnited, joining the Fortune 500 trend to ‘Bank Black’
By Jen WiecznerSeptember 3, 2020
Shares of obscure biotech firm Novavax soar 32% on coronavirus vaccine funding
Finance
Shares of obscure biotech firm Novavax soar 32% on coronavirus vaccine funding
By Jeff John RobertsJuly 7, 2020
Moderna coronavirus vaccine trial
Health
Moderna releases promising—but early—new coronavirus vaccine data
By Sy MukherjeeMay 18, 2020
Will COVID-19 change how Big Pharma does clinical trials?
Magazine
Will COVID-19 change how Big Pharma does clinical trials?
By Erika FryMay 15, 2020
Gilead-Sciences-Remdesivir
Health
Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By Sy MukherjeeMay 1, 2020
George Scangos coronavirus czar biotech
Newsletters
Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response
By Sy MukherjeeMarch 2, 2020
What Andreessen’s ‘Bio Fund III’ means for healthcare
Newsletters
What Andreessen’s ‘Bio Fund III’ means for healthcare
By Sy MukherjeeFebruary 4, 2020
1...
  • 4
  • 5
  • 6
  • 7
  • 8
...19
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.